CHILL NOT KILL
LIVE

Serial Number

99420419

Owner

Quell Therapeutics Limited

Attorney

Dmitriy Makarov

Filing Date

Sep 30, 2025

Add to watchlist:

No watchlists yet
View on USPTO

CHILL NOT KILL Trademark

Serial Number: 99420419

CHILL NOT KILL is a trademark filed by Quell Therapeutics Limited on September 30, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing). The application is currently pending registration.

Owner Contact Info

Quell Therapeutics Limited (4 trademarks)

3rd Floor, Translation & Innovation Hub
London W120BZ , GB

Entity Type: 99

Trademark Details

Filing Date

September 30, 2025

Registration Date

Not Registered

Goods & Services

Chemical and biological preparations for use in science and industry; chemical and biological preparations for non-medical purposes; preparations for genetically modifying human and animal cells [other than for medical or veterinary purposes]; reagents for use in the genetic modification of human and animal calls [other than for medical or veterinary purposes]; human and animal cells and parts thereof for scientific and research purposes; T cells for scientific and research purposes; regulatory T cells for scientific and research purposes; preparations of blood or cells extracted from humans and animals for scientific and research purposes; immunological agents and preparations for non-medical purposes; chimeric antigen receptors and preparations thereof for scientific and research purposes; antibody reagents for use in science and industry; nucleic acids; nucleic recombinant acids; synthetic deoxyribonucleic acids; viral vectors for use in science and industry; nucleic acid vectors for use in science and industry

Pharmaceutical and biological preparations for diagnostic, medical, therapeutic and prophylactic use; pharmaceutical, medical and veterinary preparations for diagnostic, therapeutic and prophylactic purposes; preparations for cell therapy; preparations for gene therapy; preparations for genetically modifying human and animal cells for diagnostic and medical purposes; human and animal cells and parts thereof for medical and veterinary purposes; T cells for medical and veterinary purposes; regulatory T cells for medical and veterinary purposes; preparations of blood or cells extracted from humans and animals which have been adapted for therapeutic purposes; pharmaceutical, medical and clinical preparations for use in treatment, amelioration and prophylaxis of diseases, disorders and suppression of the immune system; immunological agents and preparations for medical purposes; preparations for therapies to modulate the immune system; preparations for therapies for autoimmune conditions and immunological disorders; chimeric antigen receptors and therapeutic preparations thereof; antibodies; preparations for therapeutic delivery of nucleic acids; viral vectors for therapeutic and prophylactic purposes; nucleic acid vectors for therapeutic and prophylactic purposes; medical preparations containing viral vectors for therapeutic and prophylactic purposes; medical preparations containing nucleic acid vectors for therapeutic and prophylactic purposes

Pharmaceutical manufacturing and processing; biological, biotechnological and biopharmaceutical manufacturing and processing; biological tissue, blood, cell and genetic material processing; viral vector production and manufacture; gene therapy production and manufacture; custom manufacture of pharmaceutical and biological formulations and products; processing and modification of human and animal cells in the custom manufacture of pharmaceutical and biological formulations and products

Filing History

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 30, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 30, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 5, 2026 GNRN
NON-FINAL ACTION E-MAILED
Feb 5, 2026 GNRT
NON-FINAL ACTION WRITTEN
Feb 5, 2026 CNRT
ASSIGNED TO EXAMINER
Feb 4, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 30, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 30, 2025 NWOS
NEW APPLICATION ENTERED
Sep 30, 2025 NWAP